Terminated/Withdrawn
Sponsor ID
20180096
Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote MonitoringHF-eVOLUTION
Study Details
A study evaluating the impact of remotely collected data, measured using digital technologies, on the use of guideline-recommended heart failure therapy in adult participants with heart failure.
Protocol Summary
Primary Outcome Measures
Time to Change or Decision That Heart Failure Therapy is Optimal
Timeframe: Randomization to 6 months
Secondary Outcome Measures
Time to change or decision that heart failure therapy is optimal
Timeframe: Baseline to 6 months
Numerical Health Information Technology Usability Evaluation Scale for Healthcare Provider Scores (Health-ITUES-HCP)
Timeframe: Week 24
Numerical Health Information Technology Usability Evaluation Scale for Participants (Health-ITUES-Subject) Scores
Timeframe: Week 24
Change in Numerical Rating of Subject Satisfaction with Heart Failure Therapy
Timeframe: Baseline and Week 24
Change from Baseline in Kansas City Cardiomyopathy Questionnaire (KCCQ-23) Scores
Timeframe: Baseline and Week 24
Locations
Location
Tennessee Center for Clinical Trials, a division of Cardiology and Vascular Associates PLLC
Tullahoma, TN, United States, 37388
Status
Recruiting
Location
MercyOne Northeast Iowa Family Medicine and Residency
Waterloo, IA, United States, 50702
Status
Recruiting
Location
Diagnostic Cardiology Group
Chattanooga, TN, United States, 37404
Status
Recruiting
Location
Yale New Haven Hospital
New Haven, CT, United States, 06520
Status
Completed
Location
Virtua Health Inc.
Voorhees, NJ, United States, 08043
Status
Recruiting
Location
Inova Heart and Vascular Institute
Falls Church, VA, United States, 22042
Status
Recruiting
Showing {first} - {last} of {total} Results